SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
AETERNA ZENTARIS
(NQSC:AEZS Last Sale: .73 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQSC: (AEZS : $.73)
$17,162 million Market Cap at Market Close, July 1, 2022
Biomedics SubIndustry up .00% / Health Industry up .00% Today

1405, Boul. Du Parc - Technologique Research Report Earnings Snapshot - Last 11/04/18
Quebec, QU G1P 4P5 Fact Sheet
Canada Financial Statements
Phone: (418) 652-8525 Peer Comparison
Fax: (418) 652-0881 Annual Reports

Juergen Ernst, Chmn./Interim Pres./CEO, Dennis Turpin, CFO
Biopharmaceutical company focused on the development of novel therapeutic treatments, mainly in oncology and endocrinology. Formerly, AETERNA LABORATORIES INC until June 2004.
Historical Charts    Technical Analysis
No Historical Data available for AEZS

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common AEZS $.73 $.73 0 .0 $.72 $.74 43,073 $.72 $.74 23,509,871
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $17,162,206

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
04-OCT-12 AEZS Split 1 for 6
03-JUN-04 AELA Symbol Changed to AEZS
10-MAY-00 AETLF Symbol Changed to AELA

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex